Lataa...
Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase
COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is currently being treated using Remdesivir, a nucleoside analog that inhibits the RNA-dependent-RNA polymerase (RdRp). However, the enzymatic mechanism and efficiency of Remdesivir have not been determined, a...
Tallennettuna:
| Julkaisussa: | iScience |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7695572/ https://ncbi.nlm.nih.gov/pubmed/33283177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2020.101849 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|